Catalog Number |
ACM4146309-1 |
CAS |
4146-30-9 |
Structure |
|
Description |
Framycetin sulfate (Neomycin B sulfate), an aminoglycoside antibiotic, is a potent RNase P cleavage activity inhibitor with a Ki of 35 μM. Framycetin sulfate competes for specific divalent metal ion binding sites in RNase P RNA. Framycetin sulfate inhibits hammerhead ribozyme with a Ki of 13.5 μM. Framycetin sulfate, a 5″-azido neomycin B precursor, binds the Drosha site in miR-525 and is used for hepatic encephalopathy and enteropathogenic E. coli infections. |
Synonyms |
Neomycin B sulfate; Fradiomycin B sulfate |
Molecular Weight |
908.88 |
Molecular Formula |
C23H52N6O25S3 |
Canonical SMILES |
O=S(O)(O)=O.O=S(O)(O)=O.O=S(O)(O)=O.N[C@@H](C[C@H]1N)[C@@]([C@@H]([C@H]1O)O[C@@](O[C@H](CO)[C@H]2O[C@@]([C@@H]([C@@H](O)[C@@H]3O)N)([H])O[C@H]3CN)([H])[C@@H]2O)([H])O[C@H]([C@@H]([C@@H](O)[C@@H]4O)N)O[C@@H]4CN |
Purity |
≥98.0% |
Appearance |
Solid |
Storage |
Powder: -20°C,3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month. |
IC50&Target |
Aminoglycoside |
Research Areas |
Infection |
Shipping |
Room temperature in continental US; may vary elsewhere. |
Solvent&Solubility |
In Vitro: H2O : 250 mg/mL (275.06 mM; Need ultrasonic) In Vivo: 1. Add each solvent one by one: PBS Solubility: 50 mg/mL (55.01 mM); Clear solution; Need ultrasonic |
Target |
Antibiotic; Bacterial |
Our products and services are for research use only and cannot be used for any clinical purposes.